References
- Adikwu E, Brambaifa N (2013). Concentration effect, incidence and mechanism of nevirapine hepatotoxicity. Am J Pharmacol Toxicol8(1): 20–30.
- Adikwu E, Brambaifa N, Deo O, Oru-Bo PG (2013). Antiretroviral Toxicity and Oxidative Stress. Am J Pharmacol Toxicol8(4): 187–196.
- Awodele O, Agbaje EO, Adesina EA. and Akintonwa A (2011). Hepatoprotective Role of NeutrosecR on Hepatic Damage Induced by Combination of Zidovudine and Combined Anti-tuberculous Agents in Rats. Tokai J Exp Clin Med36(2): 31–36.
- Bain PJ (2003). Clinical Pathology. In Latimer KS, Mahaffey EA and Prasse KW (eds.) Duncan and Prasse’s Veterinary Laboratory Medicine. 4th ed. pp.193–214. Iowa State Press, Ames.
- Batterham M, Gold J, Naidoo D, Lux O, Sadler S, Bridle S, Ewing M, Oliver C (2001). A preliminary open label dose comparison using an antioxidant regimen to determine the effect on viral load and oxidative stress in men with HIV/AIDS. Eur J Clin Nutr55: 107–114.
- Carol SJ, Claudia GM, Srilakshmi JC (1993). Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr58: 103–105.
- Clancy J, McVicar AJ, Baird N (2002). Fundamentals of Homeostasis, in Perioperative Practice (Clancy J, McVicar AJ eds). Routledge, London.
- Costagliola C, Menzione M (1990). Effect of Vitamin E on the Oxidative state of glutathione in the plasma. Clin Physio/Biochem8: 140–143.
- Douglas KT (1987). Mechanism of action of glutathione-dependent enzymes. Adv Enzymol Relat Areas Mol Biol59: 103–167.
- Drain PK, Kupka R, Mugusi F, Fawzi WW (2007). Micronutrients in HIV-positive persons receiving highly active antiretroviral therapy Am J Clin Nutr85: 333–345.
- EMEA (2005). Efficacy and safety concerns regarding the coadministration of tenofovir disoproxil fumarate (TDF, Viread) and didanosine (ddI, Videx). EMEA Public Statement (EMEA/6231/2005). No. II/0049.
- Emejulu AA, Ujowundu CO, Igwe CU, Ouwuliri VA (2010). Hepatotoxicity of antiretroviral drugs in HIV seropositive Nigerian patients. Aust. J. Basic Applied Sci4: 4275–4278.
- Gavrila A, Sotirios T, Doweiko J, Nagy GS, Brodovicz K, Hsu W, Karchmer AW, Mantzoros CS (2003). Exercise and vitamin E intake are independently associated with metabolic abnormalities in human immunodeficiency virus–positive subjects: a cross-sectional study. Clin Infect Dis36: 1593–1601.
- Gurer H, Ozgunes H, Saygin E, Ercal, N (2001). Antioxidant effect of Taurine against Lead –induced Hepatotoxicity in rats. Pakistan J Biol Sci14(3): 219–225.
- Hess JL (1993). Antioxidants in Higher Plants (Alscher RG and Hess JL eds.) pp. 111–134. CRC press, Boca Raton.
- Hughes PJ, Cretton-Scott E, Teague A, Wensel TM (2011). Protease inhibitors for patients with HIV-1 infection: A comparative overview. P T36(6): 332–345.
- Kashou AH, Agarwal A (2011). Oxidants and antioxidants in the pathogenesis of HIV/AIDS. Open Reproductive Sci J3: 154–161.
- Onyema O, Ebenezer O, Godwin E, Agwu U, Godffery O (2006). Effect of Vitamin E on Monosodium Glutamate hepatotoxicity and Oxidative stress in rats. In J biochem biophys43: 20–24.
- Sappey C, Legrand-Poels S, Best-Belpomme M, Favier A, Rentier B, Piette J (1994). Stimulation of glutathione peroxidase activity decreases HIV type 1 activation after oxidative stress. AIDS Res Hum Retroviruses10: 1451–1461.
- Scholz RW. Graham KS. Gumpricht E. Reddy CC (1989). Mechanism of interaction of vitamin E and glutathione in the protection against membrane lipid peroxidation. Ann NY Acad Sci570: 514–517.
- Simsek S, Yuce A, Utuk AE (2006). Determination of serum malondialdehyde levels in sheep naturally infected with Dicrocoelium dendriticum. Fırat Üniver-sitesi Sağlık Bilimleri Dergisi (Veteriner) 20: 217−220.
- Singh A, Bhat TK, Sharma OP (2011). Clinical Biochemistry of Hepatotoxicity. J Clinic ToxicolS4: 001.
- Soriano V, Puoti M, Garcia-Gasco P, Rockstroh KJ, Benhamou Y, Barreiro P, Mc-Govern B (2008). Antiretroviral drugs and liver injury. AIDS22: 1–13.
- Taylor EW, Nadimpalli RG, Ramanathan CS (1997). Genomic structures of viral agents in relation to the biosynthesis of selenoproteins. Biol Trace Elem Res56: 63–91.
- Thapa BR, Walia A (2007). Liver function tests and their interpretation. Indian J Pediatr74: 663–671.
- Umar RA, Ladan MJ, Hassan SW, Sa’id Y, Abbas AY, and Oduolisaeme IB (2007). Administration of Antiretroviral Drugs has no untoward effect on Haematological profile in Albino rats. Asian J Biochem2(2): 147–151.
- US Food and Drug Administration Center for Drug Evaluation and Research [www.fda.gov]. FDA public health advisory for nevirapine (Viramunet) (19 January 2005). Available at: www.fda.gov/cder/drug/advisory/nevirapine.htm.
- Valle LGD, Hernandez RG, Avila JP (2013). Oxidative stress associated to disease progression and toxicity during antiretroviral therapy in human immunodeficiency virus infection. J Virol Microbiol2013: 1–15 DOI: 10.5171/2013.279685.
- Van Haaften RIM, Evelo CTA, Haenen GRM, Bast A (2001). Alpha Tocopherol inhibits glutathione S-transferase P1-1(GST P1-1). Biochem Biophys Res Commun280(3): 631–633.
- Wei YH, Lu CY, Lee HC, Pang CY, Ma YS (1998). Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Ann N Y Acad Sci854: 155–170.
- World Health Organization (2006). The World Health Report: Working Together for Health. 1st Edn, pp209. Geneva, ISBN-10: 241563176.
- Yamamoto T, Kikkawa R, Yamada H, Horii I (2005). Identification of oxidative stress-related proteins for predictive screening of hepatotoxicity using a proteomic approach. J Toxicol Sci30: 213–227.
- Zelen I, Mitrovic M, Jurisic-Skevin A, Arsenijevic S (2010). Activity of superoxide dismutase and catalase and content of malondialdehyde in seminal plasma of infertile patients. Med Pregl63(9–10): 624–629.
- Zhao L, Cox AG, Ruzicka JA, Bhat AA, Zhang W, Taylor EW (2000). Molecular modeling and in vitro activity of an HIV-1-encoded glutathione peroxidase. Proc Natl Acad Sci97: 6356–6361.